News
PLANET ® Onco Dose is CE Marked under new EU MDR Regulation 2017/745 since February 17 th, 2025. Learn more .
Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...
Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...
Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...
2don MSN
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...
Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...
Researchers developed light-activated cyanine-carborane salts that effectively target and destroy aggressive breast cancer ...
City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...
A teenager was airlifted to hospital with serious injuries after being hit by an RCMP vehicle Tuesday night on the ...
The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results